wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44727423-7B0D6701-BFCE-4735-AED0-8B9A90D9E77C
Q44727423-7B0D6701-BFCE-4735-AED0-8B9A90D9E77C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44727423-7B0D6701-BFCE-4735-AED0-8B9A90D9E77C
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
P2860
Q44727423-7B0D6701-BFCE-4735-AED0-8B9A90D9E77C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44727423-7B0D6701-BFCE-4735-AED0-8B9A90D9E77C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc24a57fdd615350c0df1c3eaa54d302aaf47c76
P2860
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.